StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$161.52+0.73 (+0.45%)

Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –

Novartis Consolidated Net Income by Quarter

Consolidated Net Income ($M)

QuarterlyAnnual

Novartis Consolidated Net Income: $1,196M in Q3 2026, down 69.6% from a year earlier.

Latest, Q3 2026
1,196
Period ended Sep 30, 2026
Change on a year earlier
-69.6%
3,930 in Q3 2025
History
37 quarters
Since Q2 2017
Sources
33
Documents cited below

Where the Q3 2026 figure comes from

“|| Net income | 1 196 | 3 930”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Postgres DB + Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedConsolidated Net Income ($M)Year on yearSource
Q3 2026Sep 30, 20261,196-69.6%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20263,257-19.1%Novartis 6-K (0001114448-26-000012, filed 2026-07-21) ↗
Q1 2026Mar 31, 20263,156-12.6%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20252,404-14.8%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20253,930+23.4%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 20254,024+24.0%Novartis 6-K (0001370368-25-000012, filed 2025-07-17) ↗
Q1 2025Mar 31, 20253,609+34.3%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 20242,820-66.7%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 20243,185+80.7%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 20243,246+40.1%Novartis 6-K (0001370368-24-000019, filed 2024-07-18) ↗
Q1 2024Mar 31, 20242,688+17.2%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 20238,480+478.4%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 20231,763+11.9%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 20232,317+36.7%Novartis 6-K (0001370368-23-000059, filed 2023-07-18) ↗
Q1 2023Mar 31, 20232,294+3.4%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 20221,466-91.0%Novartis Form 6-K (0001370368-24-000007) ↗

Cite this data

StockData. (2026). Novartis Consolidated Net Income ($M), quarterly Q2 2017–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-is-net-inc-cons

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.